Viatris Inc (VTRS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael Goettler
Employees:
37,000
1000 MYLAN BOULEVARD, CANONSBURG, PA 15317
(724) 514-1465

Viatris Inc. operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

Data derived from most recent annual or quarterly report
Market Cap 13.287 Billion Shares Outstanding1.212 Billion Avg 30-day Volume 15.034 Million
P/E Ratio16.7495 Dividend Yield4.3935 EPS-1.09
Price to Revenue0.7414 Debt to Equity1.06 EBITDA4.73 Billion
Price to Book Value0.6434 Operating Margin8.9377 Enterprise Value33.073 Billion
Current Ratio1.455 EPS Growth1.272 Quick Ratio0.573
1 Yr BETA 0.7371 52-week High/Low 15.31 / 9.45 Profit Margin4.4267
Operating Cash Flow Growth80.2427 Altman Z-Score0.8719 Free Cash Flow to Firm 7.261 Billion
View SEC Filings from VTRS instead.

View recent insider trading info

Funds Holding VTRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VTRS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2020-11-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-09-11:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K/A: filed on 2020-08-31:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2020-08-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2020-07-24:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2020-07-02:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2020-06-19:
    Item 8.01: Other Events
  • 8-K: filed on 2020-06-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-04-15:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TADDESE MENASSIE SEE REMARKS

    • Officer
    0 2022-05-27 6

    NI XIANGYANG (SEAN) PRESIDENT, GREATER CHINA

    • Officer
    10,321 2022-03-29 5

    KILTS JAMES M

    • Director
    79,402 2022-03-21 4

    HIGGINS MELINA E

    • Director
    137,068 2022-03-21 4

    CORNWELL W DON

    • Director
    22,197 2022-03-21 5

    COURY ROBERT J EXECUTIVE CHAIRMAN

    • Officer
    • Director
    8,391 2022-03-21 6

    KORMAN HARRY

    • Director
    50,638 2022-03-21 4

    PARRISH MARK W

    • Director
    82,250 2022-03-21 4

    DIMICK NEIL F

    • Director
    75,200 2022-03-21 4

    READ IAN C

    • Director
    14,497 2022-03-21 4

    MALIK RAJIV PRESIDENT

    • Officer
    • Director
    5,594 2022-03-21 4

    MAURO ANTHONY SEE REMARKS

    • Officer
    2,468 2022-03-21 4

    LYONS DILLON JOELLEN

    • Director
    39,564 2022-03-21 4

    CAMPBELL PAUL SEE REMARKS

    • Officer
    1,238 2022-03-21 4

    MARK RICHARD A

    • Director
    33,165 2022-03-21 4

    VAN DER MEER MOHR PAULINE

    • Director
    29,974 2022-03-21 4

    GOETTLER MICHAEL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    148,511 2022-03-21 6

    NARULA SANJEEV CHIEF FINANCIAL OFFICER

    • Officer
    2,935 2022-03-21 4

    ROMAN BRIAN GLOBAL GENERAL COUNSEL

    • Officer
    1,087 2022-03-21 4

    CUNEO ANDREW SEE REMARKS

    • Officer
    612 2022-03-21 4

    VANDERVEEN RANDALL L

    • Director
    No longer subject to file 2020-11-16 0

    BRESCH HEATHER M CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    No longer subject to file 2020-11-16 0

    CINDRICH ROBERT J

    • Director
    No longer subject to file 2020-11-16 0

    VOLLEBREGT SJOERD S

    • Director
    No longer subject to file 2020-11-16 0

    PARKS KENNETH SCOTT CHIEF FINANCIAL OFFICER

    • Officer
    35,115 2020-03-02 0

    GALLAGHER DANIEL MARTIN JR CHIEF LEGAL OFFICER

    • Officer
    No longer subject to file 2019-04-01 0

    BRESCH HEATHER M CHIEF EXECUTIVE OFFICER

    BRESCH HEATHER M CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    618,230 2019-03-01 0

    CAMERON WENDY

    • Director
    No longer subject to file 2018-06-29 0

    LEECH DOUGLAS J

    • Director
    No longer subject to file 2017-06-22 0

    MAROON JOSEPH C MD

    • Director
    No longer subject to file 2017-06-22 0

    PIATT RODNEY L

    • Director
    No longer subject to file 2017-06-22 0

    ABBOTT LABORATORIES

    ABBOTT PRODUCTS

    ABBOTT INVESTMENTS LUXEMBOURG S.A R.L.

    • 10% Owner
    No longer subject to file 2017-03-23 0

    SHEEHAN JOHN D EVP AND CFO

    • Officer
    193,732 2016-03-24 0

    ABBOTT PRODUCTS

    • 10% Owner
    62,782,018 2015-07-28 0

    ABBOTT LABORATORIES

    ABBOTT ESTABLISHED PRODUCTS HOLDINGS GIBRALTAR LTD

    ABBOTT INVESTMENTS LUXEMBOURG S.A R.L.

    • 10% Owner
    69,750,000 2015-04-07 0

    ABBOTT LABORATORIES

    LABORATOIRES FOURNIER S.A.S.

    ABBOTT ESTABLISHED PRODUCTS HOLDINGS GIBRALTAR LTD

    ABBOTT INVESTMENTS LUXEMBOURG S.A R.L.

    • 10% Owner
    75,000,000 2015-03-31 0

    TODD C B

    • Director
    229,636 2014-03-14 0

    RIZZO DANIEL C JR SVP, CORP CONTROLLER & CAO

    • Officer
    83,140 2014-03-06 0

    VARNEY JOLENE L. CHIEF FINANCIAL OFFICER

    • Officer
    0 2009-06-08 0

    PUSKAR MIKE

    • Director
    0 2009-05-07 0

    NIMMAGADDA PRASAD

    • Director
    1,205,308 2009-04-25 0

    BORKOWSKI EDWARD CHIEF FINANCIAL OFFICER

    • Officer
    78,300 2009-03-18 0

    WILLIAMS STUART A SPECIAL COUNSEL, OFFICE OF CEO

    • Officer
    110,433 2008-03-07 0

    MYERS CAROLYN J PRESIDENT, DEY L.P.

    • Officer
    8,507 2008-02-14 0

    ODONNELL JOHN CHIEF SCIENTIFIC OFFICER

    • Officer
    27,047 2006-11-21 0

    SPHAR GARY CFO, MYLAN PHARMACEUTICALS INC

    • Officer
    5,045 2006-09-15 0

    DEBONE LOUIS J PRESIDENT AND COO

    • Officer
    85,825 2006-08-21 0

    GOVIL SHARAD KUMAR VICE PRESIDENT

    • Officer
    140,650 2006-02-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VIATRIS INC VTRS 2022-08-12 18:45:03 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 18:15:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 17:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 17:15:05 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 16:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 16:15:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 15:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 15:15:05 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 14:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 14:15:05 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 13:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 13:15:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-12 12:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 22:15:03 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 21:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 21:15:03 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 20:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 20:15:03 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 19:45:04 UTC 1.9119 0.4081 0
    VIATRIS INC VTRS 2022-08-11 19:15:05 UTC 1.9119 0.4081 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund VTRS -1396.0 shares, $-26161.04 2020-12-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund VTRS -226.0 shares, $-3369.66 2020-03-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund VTRS -2475.0 shares, $-34575.75 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund VTRS -12500.0 shares, $-190500.0 2021-05-31 N-PORT
    WASATCH FUNDS TRUST- Wasatch Long/Short Alpha Fund VTRS -15147.0 shares, $-164799.36 2022-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund VTRS -4433.0 shares, $-48231.04 2022-03-31 N-PORT
    Siren ETF Trust- Siren DIVCON Dividend Defender ETF VTRS -46173.0 shares, $-502362.24 2022-03-31 N-PORT
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund VTRS -7356.0 shares, $-80033.28 2022-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VTRS -23500.0 shares, $-255680.0 2022-03-31 N-PORT

    Elevate your investments